Search Ontology:
ChEBI
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
- Term ID
- CHEBI:61711
- Synonyms
-
- (Gal)1 (GlcNAc)1 (LFuc)1 (Neu5Ac)1
- 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
- 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose
- alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-D-glucosamine
- alpha-Neu5Ac-(2->3)-beta-D-Gal (1->4)-[alpha-L-Fuc-(1->3)]-D-GlcNAc
- NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAc
- R-alpha-D-Gal-beta1,3-alpha-D-GlcNAc-(alpha1,3-Fuc)-beta1,4-D-Gal-alpha2,3-Neu5Ac
- sialyl Lewis X
- sialyl Lewis x antigen
- sialyl Lewis x mimetic
- sialyl-Lewis x antigen
- sLeX
- WURCS=2.0/4,4,3/[a2122h-1x_1-5_2*NCC/3=O][a1221m-1a_1-5][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O]/1-2-3-4/a3-b1_a4-c1_c3-d2
- Definition
- A branched amino tetrasaccharide consisting of a sialyl residue, linked (2->3) to a galactosyl residue that in turn is linked (1->4) to a glucosaminyl residue, which is also carrying a fucosyl residue at the 3-position.
- References
-
- GlyGen:G90387AM
- GlyTouCan:G90387AM
- KEGG:G00242
- PMID:10211987
- PMID:10789451
- PMID:10852628
- PMID:10969978
- PMID:11408160
- PMID:11872958
- PMID:12015815
- PMID:14601054
- PMID:16133831
- PMID:7691279
- PMID:8632441
- PMID:8818228
- PMID:8879537
- PMID:9357520
- PMID:9639536
- Reaxys:7162134
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has subtype
-
- has_role
-
- inverse has_functional_parent
-
Phenotype
Phenotype resulting from alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
Phenotype where environments contain alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
Phenotype modified by environments containing alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
Human Disease Model